Aehr Test Systems 3Q 2026: Revenue $33.01M, EPS $0.21 — 10-Q Summary

Aehr Test Systems reported 3Q 2026 revenue of $33.01M, up 200.9% YoY, driven by AI-market demand. Net income was $7.18M, up from a loss a year earlier. Gross margin improved to 47.5% due to higher volume and favorable product mix. Asia and U.S. revenue grew significantly, while Europe and Middle East revenue declined.

Original reporting
Published Nov 6, 2026, 10:11 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 6, 2026, 10:24 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Aehr Test Systems 3Q 2026: Revenue $33.01M, EPS $0.21 — 10-Q Summary — source image
Decision brief

The 30-second read

$AEHRBullishMed
01

Why it matters

The earnings surprise may trigger short covering and new buying, especially among AI‑themed funds.

02

Market read

Micro‑cap earnings with strong AI exposure; potential catalyst for sector‑wide re‑rating.

03

What to watch

The decline in Europe/Middle East sales and reliance on a single sector may expose AEHR to cyclical risk.

Relevance 6/10Novelty 7/10Timing: post‑market release

Background

AEHR Test Systems filed its 10‑Q for Q3 2026, showing a dramatic turnaround driven by AI market demand.

Company-level read

Ticker impact

$AEHRBullishHigh confidence
Context

AEHR reported Q3 2026 revenue of $33.01M and a net income of $7.18M, a 200% YoY revenue increase and a swing to profit.

Expected impact

likely upward pressure as the market prices in the profit swing and revenue surge

Evidence & confidence

First‑report earnings with a 400% EPS increase and 200% revenue growth for a micro‑cap in a hot AI sector.

Market effects

Highlights accelerating AI‑related demand for test equipment, potentially benefitting peers in semiconductor test services.

Strong Asia revenue growth may boost sentiment toward other Asian‑focused tech suppliers.

Adds to the narrative of AI‑driven growth across the technology supply chain.

Counterpoint

The rapid cost increase and higher SG&A could pressure margins if AI demand slows, suggesting caution.

Key entities

  • AEHR Test Systems

    US‑listed provider of semiconductor test equipment.

Related articles

$AEHRHighAI 9/10

Aehr Test Systems (AEHR) (Q1 2027) Earnings Call Highlights: Record Revenue, Raised

Aehr Test Systems (AEHR) reported record Q1 2027 revenue of $33M and raised annual guidance to $150M. CEO Gayn Erickson highlighted a potential large burn-in opportunity, estimating $35M-$70M in revenue per million units shipped. The company expects sequential growth in remaining quarters, with Q4 potentially the highest. Management confirmed they are not supply-constrained and can ship more than guided. Silicon carbide revenue was about $10M in fiscal 2026, with expectations for growth in 2027.

$AEHRHighAI 9/10

AEHR Stock Surges After Massive AI-Driven Earnings Beat

Aehr Test Systems (AEHR) stock rose 26.6% after reporting Q1 FY27 revenue of $33M, up 300% year-over-year and 75% quarter-over-quarter. Adjusted EPS was $0.28, beating estimates. The company raised FY27 revenue guidance to $150M, citing strong demand for AI and power semiconductor testing.

$AEHRHighAI 9/10

Aehr Stock Jumps 16% After Bookings Hit $46.7 Million

Aehr Test Systems (AEHR) shares rose 16.38% premarket after its Q1 revenue tripled to $33.0M, beating estimates. The company raised its full-year outlook to $150M, citing strong bookings and backlog growth. CEO Gayn Erickson highlighted a major AI customer opportunity. According to GuruFocus, there are 6 warning signs with AEHR.

$AEHRHighAI 8/10

Why is Aehr Test Systems stock surging today?

Aehr Test Systems (AEHR) stock surged 18.8% in pre-market trading after reporting record Q1 2027 revenue of $33.0M, up 200% YoY, and raising full-year revenue outlook to $150M. Non-GAAP net income was $9.4M, or $0.28 per share, exceeding analyst estimates. The company cited strong demand for AI semiconductor test solutions and a book-to-bill ratio of 1.4.

$AEHRMed

Aehr stock jumps on beat and raise amid AI demand

Aehr Test Systems (AEHR) shares rose 15% after reporting Q1 revenue of $33M, up 200% YoY, and raising its FY2027 outlook to $150M. The company cited strong demand for its semiconductor testing systems used in AI chips. CEO Gayn Erickson noted a conservative approach to the revised target. Bookings were $46.7M with a book-to-bill ratio of 1.4.